Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 04:00PM ET
33.88
Dollar change
+0.49
Percentage change
1.47
%
IndexRUT P/E- EPS (ttm)-0.11 Insider Own9.79% Shs Outstand155.78M Perf Week-1.11%
Market Cap5.27B Forward P/E36.00 EPS next Y0.94 Insider Trans-0.50% Shs Float140.42M Perf Month39.08%
Income-14.36M PEG- EPS next Q0.09 Inst Own65.44% Short Float20.17% Perf Quarter57.88%
Sales264.79M P/S19.92 EPS this Y-46.91% Inst Trans7.56% Short Ratio7.63 Perf Half Y104.96%
Book/sh1.23 P/B27.47 EPS next Y1869.76% ROA-3.13% Short Interest28.33M Perf Year134.95%
Cash/sh2.19 P/C15.46 EPS next 5Y- ROE-8.05% 52W Range12.84 - 36.84 Perf YTD98.36%
Dividend Est.- P/FCF- EPS past 5Y- ROI-3.23% 52W High-8.03% Beta2.22
Dividend TTM- Quick Ratio3.91 Sales past 5Y2506.46% Gross Margin88.20% 52W Low163.86% ATR (14)1.97
Dividend Ex-Date- Current Ratio4.59 EPS Y/Y TTM51.39% Oper. Margin-0.19% RSI (14)61.26 Volatility4.33% 7.52%
Employees264 Debt/Eq1.32 Sales Y/Y TTM39.53% Profit Margin-5.42% Recom1.50 Target Price38.67
Option/ShortYes / Yes LT Debt/Eq1.31 EPS Q/Q-96.70% Payout0.00% Rel Volume0.47 Prev Close33.39
Sales Surprise2.66% EPS Surprise-33.33% Sales Q/Q-49.41% EarningsNov 04 BMO Avg Volume3.71M Price33.88
SMA205.46% SMA5025.48% SMA20065.88% Trades Volume1,762,934 Change1.47%
Date Action Analyst Rating Change Price Target Change
Oct-29-24Initiated TD Cowen Buy $50
Aug-02-23Upgrade Goldman Sell → Neutral $16 → $12
Jun-26-23Resumed Jefferies Buy $55 → $40
May-20-22Initiated BofA Securities Underperform $5
Feb-23-22Reiterated B. Riley Securities Buy $49 → $35
Nov-15-21Downgrade Goldman Neutral → Sell $33 → $26
Apr-20-21Initiated Goldman Neutral $50
Apr-19-21Reiterated H.C. Wainwright Buy $79 → $89
Sep-01-20Initiated JP Morgan Overweight $38
Aug-11-20Reiterated H.C. Wainwright Buy $32 → $38
Nov-29-24 08:00AM
Nov-26-24 06:45AM
Nov-21-24 12:35PM
06:00AM
Nov-05-24 02:02AM
01:17AM Loading…
01:17AM
Nov-04-24 04:15PM
04:07PM
09:00AM
08:10AM
07:06AM
07:00AM
Nov-01-24 08:06AM
Oct-31-24 03:44PM
Sep-21-24 12:38AM
04:20PM Loading…
Sep-18-24 04:20PM
04:09PM
03:29PM
02:41PM
01:44PM
12:28PM
10:46AM
07:15AM
07:00AM
Sep-06-24 06:43PM
01:31PM
Sep-05-24 07:30AM
Aug-30-24 10:38AM
Aug-19-24 04:00PM
Aug-16-24 04:23PM
04:32AM Loading…
Aug-12-24 04:32AM
Aug-06-24 04:00PM
09:46AM
08:15AM
07:18AM
07:00AM
Aug-05-24 07:30AM
Jul-12-24 01:22PM
Jun-26-24 10:05AM
Jun-21-24 03:09AM
Jun-11-24 08:45AM
Jun-07-24 07:50AM
Jun-03-24 07:30AM
May-31-24 07:30AM
May-28-24 07:30AM
May-03-24 09:33AM
05:56AM
May-02-24 03:05AM
12:27AM
May-01-24 11:53AM
08:34AM
08:30AM
07:32AM
07:00AM
Apr-30-24 04:55PM
09:35AM
Apr-27-24 09:37AM
Apr-18-24 07:30AM
07:00AM
Apr-15-24 07:30AM
Mar-13-24 07:07AM
Mar-08-24 07:30AM
Mar-01-24 07:30AM
Feb-29-24 09:22AM
Feb-28-24 10:24PM
04:05PM
08:10AM
07:52AM
07:21AM
07:00AM
Feb-27-24 07:30AM
Feb-26-24 07:00AM
Feb-23-24 07:30AM
Feb-20-24 10:00AM
07:30AM
Feb-13-24 07:20AM
Jan-22-24 06:30AM
Jan-10-24 04:09PM
09:33AM
07:00AM
Jan-09-24 09:03AM
07:00AM
Jan-06-24 05:02AM
Jan-05-24 07:30AM
Dec-15-23 10:22AM
Dec-07-23 03:31PM
Nov-27-23 07:30AM
Nov-06-23 09:55AM
09:27AM
Nov-03-23 07:30AM
Nov-01-23 12:18PM
10:21AM
09:17AM
07:43AM
07:30AM
Oct-30-23 07:30AM
Oct-14-23 01:15PM
Oct-12-23 11:00AM
Oct-11-23 10:30AM
Oct-06-23 08:30AM
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lonial SagarDirectorNov 11 '24Sale30.445,000152,200100,195Nov 12 05:02 PM
Charney Laurence NDirectorNov 11 '24Sale30.2025,000754,875212,479Nov 12 05:01 PM
Charney Laurence NDirectorNov 11 '24Proposed Sale30.1925,000754,873Nov 12 11:36 AM
Lonial SagarDirectorNov 11 '24Proposed Sale30.445,000152,200Nov 12 11:12 AM
Echelard YannDirectorNov 05 '24Sale24.4820,000489,600224,098Nov 07 04:35 PM
Echelard YannDirectorNov 05 '24Proposed Sale24.4820,000489,500Nov 05 01:42 PM
Lonial SagarDirectorJun 20 '24Sale16.8716,348275,791105,195Jun 20 06:07 PM
Lonial SagarDirectorJun 17 '24Sale16.399,585157,09899,293Jun 20 06:07 PM
Lonial SagarDirectorMar 13 '24Sale15.945,00079,675108,878Mar 15 04:37 PM
Charney Laurence NDirectorMar 12 '24Sale15.9722,000351,340215,229Mar 13 04:52 PM
Charney Laurence NDirectorJan 05 '24Sale19.0317,500333,025237,229Jan 08 06:33 PM
Power Sean ACFOJan 03 '24Sale16.9147,867809,431606,969Jan 05 05:00 PM